It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
DNTCF’s FA Score shows that 0 FA rating(s) are green whileSYRA’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
SYRA’s TA Score shows that 2 TA indicator(s) are bullish.
DNTCF (@Medical/Nursing Services) experienced а -1.37% price change this week, while SYRA (@Medical/Nursing Services) price change was -9.75% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -4.80%. For the same industry, the average monthly price growth was -4.08%, and the average quarterly price growth was +1669.16%.
SYRA is expected to report earnings on Oct 29, 2024.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
DNTCF | SYRA | DNTCF / SYRA | |
Capitalization | 1.08B | 8.86M | 12,176% |
EBITDA | 192M | -2.84M | -6,770% |
Gain YTD | 35.970 | -63.552 | -57% |
P/E Ratio | N/A | N/A | - |
Revenue | 1.33B | 5.52M | 24,080% |
Total Cash | 111M | 3.28M | 3,384% |
Total Debt | 1.38B | 248K | 554,839% |
SYRA | |
---|---|
RSI ODDS (%) | N/A |
Stochastic ODDS (%) | 2 days ago90% |
Momentum ODDS (%) | 2 days ago90% |
MACD ODDS (%) | N/A |
TrendWeek ODDS (%) | 2 days ago90% |
TrendMonth ODDS (%) | 2 days ago90% |
Advances ODDS (%) | N/A |
Declines ODDS (%) | 2 days ago90% |
BollingerBands ODDS (%) | 2 days ago67% |
Aroon ODDS (%) | 2 days ago90% |
A.I.dvisor tells us that DNTCF and FSNUY have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DNTCF and FSNUY's prices will move in lockstep.
Ticker / NAME | Correlation To DNTCF | 1D Price Change % | ||
---|---|---|---|---|
DNTCF | 100% | N/A | ||
FSNUY - DNTCF | 25% Poorly correlated | -0.89% | ||
USNU - DNTCF | 23% Poorly correlated | N/A | ||
SYRA - DNTCF | 6% Poorly correlated | -3.54% | ||
WHTCF - DNTCF | 2% Poorly correlated | -3.15% | ||
ASTH - DNTCF | 0% Poorly correlated | -0.02% | ||
More |
A.I.dvisor tells us that SYRA and MODV have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SYRA and MODV's prices will move in lockstep.
Ticker / NAME | Correlation To SYRA | 1D Price Change % | ||
---|---|---|---|---|
SYRA | 100% | -3.54% | ||
MODV - SYRA | 28% Poorly correlated | -4.63% | ||
ADUS - SYRA | 20% Poorly correlated | -0.99% | ||
DCGO - SYRA | 10% Poorly correlated | -1.18% | ||
PIII - SYRA | 10% Poorly correlated | -16.21% | ||
BTMD - SYRA | 8% Poorly correlated | -2.23% | ||
More |